Russia approves ‘Sputnik Light’ single dose corona vaccine, claims to be 80% effective

0
210
Spread the love

New Delhi: The manufacturer of the Sputnik V vaccine in Russia has brought a single-dose vaccine named ‘Sputnik Light’. According to information provided by the company, this revolutionary one-shot vaccine has 80 per cent efficacy, which is higher than many two-shot vaccines. Sputnik lights are authorized for use in Russia.

Sputnik V producer launches Sputnik Lite

The Russian producer has resorted to its official Twitter handle to announce this good news. “The single-dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analysed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination programme between 5 December 2020 and 15 April 2021,” the RDIF said in a statement. The producers said in the next tweet that Sputnik V Lite is a ‘fast and reliable’ epidemic fighter.

The tweet stated, “It helps in reducing the high level of virus and helping to create sustainable security in the community as well as achieving a high level of security.”

Enumerating many more benefits of the vaccine, the company stated that Sputnik V would be their original vaccine, already approved in 64 countries with a combined population of 3.2 billion people.

Know about the Sputnik V vaccine

Developed by the Gamalaya National Research Institute of Epidemiology and Microbiology and supported by the Russian Sovereign Wealth Fund, Sputnik V is a vaccine based on human adenoviral winners. It is one of three vaccines in the world (the other two being Pfizer and Moderna), which have more than 90 per cent efficacy against coronavirus disease, caused by SARS-CoV-2. India gave its emergency approval on 12 April and became the 60th country to do so.

This will be the third vaccine used against the coronavirus in India. The remaining two vaccines are made in India – the first being the Covishield manufactured by the Serum Institute in collaboration with Oxford-AstraZeneca and the second being the Covaxin manufactured by Bharat Biotech. Significantly, these are the two vaccines currently used in India’s vaccination campaign.

LEAVE A REPLY

Please enter your comment!
Please enter your name here